Bottoms Up with Bon Jovi: Rocker Set to Launch New Wine
Jon Bon Jovi and his son, Jesse Bongiovi, are longtime fans of rosé. That is why the father-son duo is going into the industry together with a brand new line, "Hampton Water."
Jesse Bongiovi joins Cheddar ahead of the launch of his new rosé. He gives Cheddar a sneak peak and explains why rosé was the right move for his rocker dad and himself.
Jon Bon Jovi has jokingly called rosé "pink juice," but was immediately interested in something bigger when his son came up with the name Hampton Water.
Bongiovi explains that he wanted his rosé to be the best of the best. They settled on a region that no one was producing rose from.
When asked what his favorite Jon Bon Jovi song is, Jesse Bongiovi said his personal favorite is Bed of Roses.
Hampton Water should be on shelves by the end of the month or early March.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
